Allergologie und Immunologie
In internationalen peer-reviewten Fachzeitschriften veröffentlichte Artikel:
A1. TAT, Tugba Songul. Higher Levels of Depression and Anxiety in Patients with Chronic Urticaria. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2019;25:115.
A2. TAT, Tugba Songul. Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study. Medical Science Monitor. 2018;24:8977.
A3. Tat TS, Cilli A. Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma. Ann Allergy Asthma Immunol. 2016 Nov;117(5):546–549.
A4. Tat TS, Cilli A. Omalizumab treatment in asthma-COPD overlap syndrome. J Asthma. 2016 Dec;53(10):1048–1050.
A5. Kaynar K, Songul Tat T, Ulusoy S. Evaluation of nutritional parameters of hemodialysis patients. Hippokratia. 2012 Jul;16(3):236–240.
A6. Sonmez M, Erkut N, Tat TS. Can a high platelet count be responsible for diabetes insipidus in acute myelogenous leukemia with monosomy 7 and inversion 3 (q21q26)? Int J Hematol. 2009 Sep;90(2):273–274.
A7. TAT, Tuğba Songül. Thyroid autoimmunity and increased neutrophil-lymphocyte ratio in patients with chronic urticaria. Turkish Journal of Clinics and Laboratory. 2019;10(1):52–56.
A8. Tat, Tuğba Songül; Çilli, Aykut. Omalizumab therapy in patients with severe allergic asthma. Istanbul Medical Journal. 2017;18(3).
A9. Tat, Tuğba Songül. Efficacy and safety of omalizumab in chronic spontaneous urticaria: a naturalistic study. Cukurova Medical Journal. 2018;43(4):1–1.
In nationalen peer-reviewten Fachzeitschriften veröffentlichte Artikel:
B1. Tat, Tuğba Songül, et al. IL-10 and IL-17 Gene Polymorphism in Adult Patients with Idiopathic Thrombocytopenic Purpura. Namık Kemal Medical Journal. 2018;6(2):36–44.
B2. Bayçelebi G, Aydın F, Gökosmanoğlu F, Tat TS, Varım C. Awareness of cancer screening tests in Trabzon. Journal of Human Rhythm. 2015;1(3):90–94.
Auf peer-reviewten Kongressveranstaltungen veröffentlichte Beiträge:
C1. Tat, Tuğba Songül. Incorrect use of inhaler devices in asthma patients. 3rd International Postgraduate Education Congress. 11.–13. Mai 2018, Manisa.
C2. Tat, Tuğba Songül. A reliable treatment option for allergic rhinitis and asthma: Subcutaneous allergen immunotherapy. Medi-Trio 3 Congress. 4.–7. Oktober 2018, Zypern.
C3. Tat, Tuğba Songül. Autoimmunity in Chronic Urticaria Patients. 26th National Allergy & Clinical Immunology Congress. 9.–13. November 2019, Antalya.
C4. Tat, Tuğba Songül. Reliability of Inhalant Allergens Immunotherapy: Our Single-Center Experience. 25th National Allergy & Clinical Immunology Congress. 17.–21. November 2018, Antalya.
C5. Tat, Tuğba Songül. High error rates in inhaler devices in asthma patients; reliability of allergen immunotherapy. 25th National Allergy & Clinical Immunology Congress. 17.–21. November 2018, Antalya.
C6. Tat, Tuğba Songül; Dirol, Hülya. A lymphoma case presenting only with itching. 24th National Allergy & Clinical Immunology Congress. 18.–22. November 2017, Antalya.
C7. Tuğba Songül Tat, Aykut Çilli. Could platelet-lymphocyte ratio be a marker in sarcoidosis? 20th Thoracic Congress, Belek, 2017.
C8. Tuğba Songül Tat, Aykut Çilli. Which age group is affected by sarcoidosis? 20th Thoracic Congress, Belek, 2017.
C9. Tat TS. Outcomes of anti-IgE therapy longer than 36 months in patients with uncontrolled allergic asthma. 23rd National Allergy & Clinical Immunology Congress. Bodrum, 2016.
C10. Tat TS. A lymphoma case presenting with pruritus. 23rd National Allergy & Clinical Immunology Congress. Bodrum, 2016.
C11. Tat TS. Our experience with omalizumab in treatment-resistant chronic urticaria patients. 23rd National Allergy & Clinical Immunology Congress. Bodrum, 2016.
C12. Tat TS. Neutrophil-lymphocyte ratio in sarcoidosis. 18th Internal Medicine Congress, Belek, 2016.
C13. Tat TS. A case of primary immunodeficiency diagnosed during investigation of recurrent pulmonary infections. 18th Internal Medicine Congress, Belek, 2016.
C14. Tat TS. Monthly medication report distribution issued by an internal medicine specialist. 18th Internal Medicine Congress, Belek, 2016.
C15. Dirol, Hülya; Tat TS. Bronchiectasis and primary immunodeficiency case with delayed diagnosis. 19th Thoracic Congress, Belek, 2016.
C16. Çiğdem Çiçek Kolak, Tuğba Songül Tat, Melike Şahiner, Dilara İnan. How should cotrimoxazole hypersensitivity in HIV infection be managed? A case report. Klimik 2016, Antalya.
C17. Tat TS. A case of hypogammaglobulinemia complicated by proteinuria: Focal Segmental Glomerulosclerosis. 22nd National Allergy & Clinical Immunology Congress, Belek, 2015.
C18. Tat TS. How long does a successful cotrimoxazole desensitization last? Case report and literature review. 22nd National Allergy & Clinical Immunology Congress, Belek, 2015.
C19. Tat TS. Autoimmunity and common variable immunodeficiency. 22nd National Allergy & Clinical Immunology Congress, Belek, 2015.
C20. Tat TS. A case of primary immunodeficiency with extensive bronchiectasis. 19th Thoracic Congress, Belek, 2015.
C21. Özlem Çakın, Tuğba Songül Tat, Ozan Salim, Melike Cengiz, Atilla Ramazanoğlu. Intensive care desensitization experience in a patient who developed anaphylaxis with L-asparaginase. 12th National Internal & Surgical Medical Intensive Care Congress, Ankara, 2015.
